| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |